USP21 and esophageal squamous cell carcinoma: Kaplan-Meier analyses demonstrated that ESCC patients with high USP21 levels displayed a shorter overall survival (OS) and progression-free survival (PFS) than patients with low expression of USP21 (Fig. 1G, H).